Burcon to Present at the 14th Annual Needham Healthcare Conference on April 15, 2015
April 02 2015 - 1:00PM
Burcon NutraScience Corporation (TSX:BU)
(Nasdaq:BUR), a leader in functional, renewable plant proteins, has
been invited to present at the 14th Annual Needham Healthcare
Conference being held April 14 – 15, 2015 at the Westin Grand
Central Hotel in New York.
Burcon is scheduled to present at 8:40 a.m. Eastern Time on
Wednesday, April 15, 2015, with one-on-one meetings held throughout
the conference. Management will discuss the company's recent
financial and operational progress, including its award-winning
CLARISOY™ soy protein and the exclusive marketing and production
license to Archer Daniels Midland Company. Management will also
discuss its commercialization plans for Peazazz™, its proprietary
clean-tasting and uniquely soluble pea protein.
For additional information or to schedule a one-on-one meeting
with Burcon management, please contact your Needham
representative.
To learn more about Needham & Company and the 14th Annual
Needham Healthcare Conference, please visit www.needhamco.com.
About Burcon NutraScience Corporation
Burcon NutraScience is a leader in developing functionally and
nutritionally valuable plant-based proteins. The company has
developed a portfolio of composition, application, and process
patents originating from a core protein extraction and purification
technology. Burcon's CLARISOY™ soy protein offers clarity and
high-quality protein nutrition for low pH beverage systems and
excellent solubility and exceptionally clean flavor at any pH;
Peazazz® is a uniquely soluble and clean-tasting pea protein; and
Puratein®, Supertein™ and Nutratein® are canola protein isolates
with unique functional and nutritional attributes. For more
information about the company, visit www.burcon.ca.
ON BEHALF OF THE BOARD OF DIRECTORS "Johann F. Tergesen" Johann
F. Tergesen President and Chief Operating Officer
The TSX has not reviewed and does not accept responsibility for
the adequacy of the content of the information contained herein.
This press release contains forward-looking statements or
forward-looking information within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995 and applicable Canadian
securities legislation. Forward-looking statements or
forward-looking information involve risks, uncertainties and other
factors that could cause actual results, performances, prospects
and opportunities to differ materially from those expressed or
implied by such forward-looking statements. Forward-looking
statements or forward-looking information can be identified by
words such as "anticipate," "intend," "plan," "goal," "project,"
"estimate," "expect," "believe", "future," "likely," "may,"
"should," "could", "will" and similar references to future periods.
All statements other than statements of historical fact included in
this release are forward-looking statements, including, without
limitation, statements regarding plans and timing for the
introduction or enhancement of our products, statements about the
type of business structure with potential strategic partners,
statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained
in this press release. There can be no assurance that such
statements will prove to be accurate and actual results and future
events could differ materially from those anticipated in such
statements or information. Important factors that could cause
actual results to differ materially from Burcon's plans and
expectations include the actual results of business negotiations,
marketing activities, adverse general economic, market or business
conditions, regulatory changes and other risks and factors detailed
herein and from time to time in the filings made by Burcon with
securities regulators and stock exchanges, including in the section
titled "Risk Factors" in Burcon's annual information form dated
June 23, 2014 filed with the Canadian securities administrators on
www.sedar.com and contained in Burcon's 40-F filed with the U.S.
Securities and Exchange Commission on www.sec.gov. Any
forward-looking statement or information only speaks as of the date
on which it was made and, except as may be required by applicable
securities laws, Burcon disclaims any intent or obligation to
update any forward-looking statement, whether as a result of new
information, future events or otherwise. Although Burcon believes
that the assumptions inherent in the forward-looking statements are
reasonable, forward-looking statements are not guarantees of future
performance, and accordingly, investors should not rely on such
statements.
CLARISOY is a trademark of Archer Daniels Midland Company.
CONTACT: Media & Industry Contact:
Michael Kirwan
Director, Corporate Development
Burcon NutraScience Corporation
Tel (604) 733-0896, Toll-free (888) 408-7960
mkirwan@burcon.ca
www.burcon.ca
Burcon NutraScience (TSX:BU)
Historical Stock Chart
From Jun 2024 to Jul 2024
Burcon NutraScience (TSX:BU)
Historical Stock Chart
From Jul 2023 to Jul 2024